Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: Netherlands Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20053
20061
20072
20103
20111
20121
20134
20142
20161
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Bristol-Myers Squibb6
Pfizer3
Ariad Pharmaceuticals1
Children's Oncology Group1
European LeukemiaNet1
Gamida Cell ltd1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive24
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia5
Bone Marrow Diseases3
Bronchiolitis Obliterans Syndrome2
Hematologic Diseases2
Hematologic Neoplasms2
Leukemia, Myeloid2
Philadelphia Chromosome2
Blast Crisis1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.